Parasitosis febriles

  1. Vázquez, E. García 1
  2. Torres, A. Hernández
  3. Escudero, E. Moral
  4. Martínez, J.A. Herrero
  5. Gómez, J. Gómez
  6. Hernández, M. Segovia
  1. 1 Universidad de Murcia
    info
    Universidad de Murcia

    Murcia, España

    ROR https://ror.org/03p3aeb86

    Geographic location of the organization Universidad de Murcia
Journal:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Year of publication: 2018

Series: 12

Issue: 57

Pages: 3369-3376

Type: Article

DOI: 10.1016/J.MED.2018.05.004 DIALNET GOOGLE SCHOLAR

More publications in: Medicine: Programa de Formación Médica Continuada Acreditado

Sustainable development goals

info

SDG classification obtained using Aurora SDG artificial intelligence model.

Abstract

Although there are many parasitic infections that can affect human beings, parasitoses that present with fever are rarer and can be summarised as 7 parasites: Plasmodium spp., Leishmania spp., Babesia spp., Entamoeba histolytica, Toxoplasma gondii, Trichinella spiralis and Schistosoma spp.. Other protozoa and helminths can cause fever, but they are less common in our environment (acute Trypanosoma spp. infections). Malaria must be ruled out in any patient who has recently been to a malaria-affected area. Therefore, the presence of acute fever in a traveller who has come from any of these areas would indicate malaria unless there is evidence to the contrary. Leishmaniasis, by contrast, is an imported and endemic infection in the Mediterranean basin; its presentation is subacute, as a prolonged febrile syndrome. Babesiosis is extremely rare in our environment, as are non-imported trichinosis or amebiasis. Acute infection with schistosomiasis presents with fever (Katayama fever) and is only epidemiologically possible in countries where the vector (snail) is present.

Bibliographic References

  • Alp E, Erdem H, Rello J. Management of septic shock and severe infections in migrants and returning travelers requiring critical care. Eur J Clin Microbiol Infect Dis. 2016;35:527-33.
  • Arsuaga M, González LM, Lobo CA, de la Calle F, Bautista JM, Azcárate IG. First Report of Babesia microti caused babesiosis in Spain. Vector Borne Zoonotic Dis. 2016;16:677-9
  • Bern C. Chagas disease: Acute and congenital Trypanosoma cruzi infection. UpToDate.
  • Bern C. Treatment of visceral leishmaniasis. UpToDate.
  • Bern C, Martin DL, Gilman RH. Acute and congenital Chagas disease. Adv Parasitol. 2011;75:19.
  • Bern C. Clinical manifestations and diagnosis of visceral leishmaniasis. UpToDate. D
  • Breman JG. Clinical manifestations of malaria in nonpregnant adults and children.
  • Català A, Roé E, Dalmau J, Pomar V, Muñoz C, Yelamos O, Puig L. Antitumour necrosis factor induced visceral and cutaneous leishmaniasis: case report and review of the literature. Dermatology. 2015;230:204-7.
  • Clerinx J, Soentjens P. Epidemiology, pathogenesis, and clinical manifestations of schistosomiasis. UpToDate.
  • Clerinx J, Van Gompel A. Schistosomiasis in travellers and migrants. Travel Med Infect Dis. 2011;9:6.
  • Cordero del Campillo M. Parasitic zoonoses in Spain. Int J Zoonoses. 1974;1:43-57.
  • González LM, Castro E, Lobo CA, Richart A, Ramiro R, González-Camacho F. First report of Babesia divergens infection in an HIV patient. Int J Infect Dis. 2015;33:202-4.
  • Jiménez-Marco T, Fisa R, Girona-Llobera E, Cancino-Faure B, Tomás-Pérez M, Berenguer D. Transfusion transmitted leishmaniasis: a practical review. Transfusion. 2016;56 Suppl 1:S45-51.
  • Kociecka W. Trichinellosis: human disease, diagnosis and treatment. Vet Parasitol. 2000;93:365.
  • Malvy D, Chappuis F. Sleeping sickness. Clin Microbiol Infect. 2011; 17:986.
  • Mensa J, Gatell JM, García-Sánchez JE, Letang E, López- Suñé E, Marco F. Guía de terapéutica antimicrobiana. Barcelona: Editorial Antares; 2017.
  • Monge-Maillo B, López-Vélez R. Therapeutic options for visceral leishmaniasis. Drugs. 2013;73:1863-88.
  • Monge-Maillo B, López-Vélez R. Treatment options for visceral leishmaniasis and HIV coinfection. AIDS Rev. 2016;18:32-43.
  • Monge-Maillo B, Norman FF, Cruz I, Alvar J, López-Vélez R. Visceral leishmaniasis and HIV coinfection in the Mediterranean region. PLoS Negl Trop Dis. 2014:21;8:e3021
  • Pépin J, Méda HA. The epidemiology and control of human African trypanosomiasis. Adv Parasitol. 2001;49:71.
  • Pérez-Molina JA, Molina I. Chagas disease. Lancet. 2018;391(10115): 82-94.
  • Peters W, Gilles HM. Tropical medicine and parasitology. 4th ed. Barce-lona: Mosby-Wolfe;1997.
  • Ross AG, Vickers D, Olds GR, Shah SM, McManus DP. Katayama syndrome. Lancet Infect Dis. 2007;7:218.
  • Stanaway JD, Roth G. The burden of Chagas disease: estimates and challenges. Glob Heart. 2015;10:139-44.
  • Teunis PF, Koningstein M, Takumi K, van der Giessen JW. Human beings are highly susceptible to low doses of Trichinella spp. Epidemiol Infect. 2012;140:210.
  • Uslan DZ, Jacobson KM, Kumar N, Berbari EF, Orenstein R. A woman with fever and rash after African safari. Clin Infect Dis 2006;43:609, 661.
  • Vannier EG, Diuk-Wasser MA, Ben Mamoun C, Krause PJ. Babesiosis. Infect Dis Clin North Am. 2015;29:357-70.
  • Weller PF. Trichinellosis. UpToDate.
  • World Health Organization. Guidelines for the treatment of malaria, 3rd ed, WHO, Geneva 2015
Data source: Dialnet